[I87E mutation prevents barstar dimerization].

Area of Science:

• Biochemistry
• Molecular Biology
• Protein Engineering

Background:

• Barstar is an intracellular inhibitor of ribonuclease barnase from Bacillus amyloliquefaciens.
• Wild-type barstar forms homodimers in aqueous solution, which can complicate certain experimental applications.
• Investigating protein-protein interactions requires precise control over protein behavior.

Purpose of the Study:

• To create and characterize a C40,82A;I87E mutant of barstar.
• To evaluate the physicochemical properties of the mutant, focusing on its structure, dimerization behavior, and binding affinity to barnase.
• To determine the utility of the mutant in applications where barstar dimerization is undesirable.

Main Methods:

• Production of the C40,82A;I87E barstar mutant as a thioredoxin fusion protein.
• Cleavage of the fusion protein using EKmax enterokinase.
• Structural analysis using Nuclear Magnetic Resonance (NMR) spectroscopy.
• Determination of binding affinity to barnase via dissociation constant measurements.

Main Results:

• The C40,82A;I87E barstar mutant was successfully produced and purified.
• NMR analysis confirmed that the mutant retains the spatial structure of the wild-type protein.
• Unlike wild-type barstar, the mutant does not form homodimers in aqueous solution.
• The mutant exhibits high affinity for barnase, with a dissociation constant of (6.6 +/- 1.1) x 10(-11) M.
• Other physicochemical properties of the mutant are comparable to wild-type barstar.

Conclusions:

• The C40,82A;I87E barstar mutant is a stable protein that mimics the wild-type structure and barnase-binding capacity.
• The absence of homodimerization in the mutant makes it a valuable tool for specific biochemical and structural studies.
• This mutant offers an alternative to wild-type barstar in experimental settings where protein dimerization can interfere with results.